REFERENCES REGARDING MYASTHENIA GRAVIS AND CANNABINOID EFFECTS ON ACETYLCHOLINESTERASE

At Greenbridge Medical, we have now just followed up with our 7th Myasthenia Gravis patient who, as the six previous, is now doing well. That means seven patients in a row who have been able to stop their Prednisone, Mestanon and even IVIG therapy in one patient. As we find more clinical data in our practice or published, we will try post as much as quickly as possible. We are seeing vast improvements in both small ocular/facial muscles as well as with more generalized larger muscle groups.

HERE ARE SOME REFERENCES:

Effects of cannabinoids on levels of acetylcholine and choline and on …

Cited by 18 – ‎Related articles

Cited by 120 – ‎Related articles

Cited by 3 – ‎Related articles

Cited by 119 – ‎Related articles

Effect of cannabinoids on the turnover rate of acetylcholine in rat …

Cited by 30 – ‎Related articles

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.